Company intelligence / Profile preview

Predictive Technologies

Salt Lake City, Utah, United Statespredictive-technologies.com ↗

Ownership: Private
Employees: ~5
Development stage: Commercial

Overview

Predictive Technology Group developed commercialized molecular diagnostic tests for infertility/endometriosis and marketed human cell/tissue products for regenerative medicine. The company filed for Chapter 11 bankruptcy in November 2023, which was converted to Chapter 7 liquidation in January 2024.

Therapeutic areas: OtherNeurologyWomen's Health
Modalities: Human cellular and tissue-based productsGenetic testingSmall molecule
Industry: Biotech

Partnerships

Atrin Pharmaceuticals LLC (molecular diagnostic tools for cancer patient selection)

Beyond the preview

Go deeper on Predictive Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Predictive Technologies.

Explore the full profile